The trademark application IGPS was filed by Kelonia Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 11, 2023, and it was registered by office on July 19, 2023 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and professional address of the trademark registration was recorded on March 20, 2024. Change of name and address of the trademark registration was recorded on May 29, 2024. Change of name and address of the trademark registration was recorded on June 16, 2024. Change of name and address of the trademark registration was recorded on June 16, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical, medical and clinical preparations for use in cell and gene therapy
Pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases
Cell and gene therapy vectors for treatment of cancer and genetic diseases
Therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments
T-cells for medical and therapeutic use
Pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases.
The mark was filed in class 42 with Scientific and medical research services in the field of cell and gene therapies and Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors..